Abivax
FranceEntry
2023
Hold
3yr
Status
Active
Who owns Abivax?
Abivax is currently owned by Andera Partners through BioDiscovery 6 (2022 vintage), since 2023. Across its history, Abivax has been through 3 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Most recent investor
Andera PartnersBioDiscovery 6 · 2022 · VC
4 ownership periods · full history below
Key facts
Ownership history
3 ownership periods · co-invest detected · 1 lender on file
Active
Co-invest · 3 holders · 1 lender · 2013 · present
Truffle CapitalActive
2013 · present(13yr) · Truffle Capital Legacy (pre-2019) · 2010 · VC
Sofinnova PartnersActive
2018 · present(8yr) · Sofinnova Crossover Fund I · 2018 · VC
Andera PartnersActive
2023 · present(3yr) · BioDiscovery 6 · 2022 · VC
Claret Capital PartnersLender
2023 · present(3yr) · Claret European Growth Capital Fund III · 2021 · Private Debt
More from BioDiscovery 6
Other portfolio companies in the same fund.
USMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Track Abivax
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Abivax?
5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Abivax.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue